Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
QIAGEN Launches New Secondary Analysis Solution Tailored for Oncology and Inherited Disease Bioinformatics Workflows
Friday, May 03, 2024QIAGEN has introduced QCI Secondary Analysis a cloudbased softwareasaservice solution that facilitates highthroughput secondary analysis for clinical nextgeneration sequencing
Aileron Therapeutics Announces Positive Results from First Cohort of Phase 1b Clinical Trial Assessing LTI-03 for Idiopathic Pulmonary Fibrosis (IPF)
Thursday, May 02, 2024Aileron Therapeutics Inc a biopharmaceutical company focused on developing treatments for orphan pulmonary and fibrosis conditions has shared encouraging results from Cohort of its Phase b clinical trial
Galecto Starts Phase 2 Trial with First Patient Dosed in Investigator-Initiated Study Combining GB1211 and Pembrolizumab
Thursday, May 02, 2024Galecto Inc a biotech company specializing in pioneering cancer and fibrosis treatments has reached a significant milestone in its clinical journey Theyve initiated an investigatorled Phase trial at the Earle A
ONO Announces Agreement to Acquire Deciphera Pharmaceuticals
Wednesday, May 01, 2024ONO Pharmaceutical Co Ltd with Gyo Sagara as Representative Director Chairman of the Board and Chief Executive Officer and Deciphera Pharmaceuticals Inc led by Chief Executive Officer Steven L Hoerter have announced a definitive merger agreement
Soleno Therapeutics Secures FDA Breakthrough Therapy Designation for DCCR Extended-Release Tablets Targeting Prader-Willi Syndrome (PWS)
Tuesday, April 30, 2024Soleno Therapeutics Inc has announced that the US Food and Drug Administration granted Breakthrough Therapy Designation to diazoxide choline for the treatment of adults and children aged
AriBio Granted EMA Authorization for Phase 3 Clinical Trial of AR1001 in Alzheimer’s Treatment (POLARIS-AD)
Monday, April 29, 2024AriBio Co Ltd has received approval from the European Medicines Agency for POLARISAD a phase clinical trial targeting early Alzheimers disease This approval aligns with similar authorizations
Apollomics Receives Approval in China for Vebreltinib, a Novel Treatment Targeting Gliomas with MET Fusion Gene
Friday, April 26, 2024Apollomics Inc has announced a significant development regarding vebreltinib in China The National Medical Products Administration has granted approval to Avistone Biotechnology Co Ltd
Avistone Secures Approval for Vebreltinib as Initial MET-TKI Therapy for Rare Brain Glioma Subtype in China
Friday, April 26, 2024Beijing Avistone Biotechnology Co Ltd has gained approval from the Chinese National Medical Products Administration to extend the application of vebreltinib for treating adult patients
Hyundai Bioscience Reveals Clinical Strategy for Niclosamide-Based Metabolic Anticancer Treatment Aimed at P53 Mutation-Associated Cancer
Friday, April 26, 2024Hyundai Bioscience made headlines on April th with its breakthrough announcement regarding the development of an oral anticancer drug targeting patients with intractable cancers
Junshi Biosciences Gets NDA Approval for Toripalimab in Hong Kong
Thursday, April 25, 2024Junshi Biosciences a leading biopharmaceutical company dedicated to innovative therapies has announced the acceptance of its New Drug Application by the Drug Office of the Hong Kong Special Administrative Region This NDA relates to toripalimab propos...
